Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2011; 57(5): 26-29


Physiology of Toll-like receptors--regulators of natural and acquired immunity

Berezhnaia NM1, Sepiashvili RI2

  1. R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Kiev, Ukraine
  2. Institute of Immunophysiology, Moscow, Russia
DOI: https://doi.org/10.15407/fz57.05.026

Abstract

Keywords: TOLL-like receptor regulators, immunity

References

  1. Sepiashvili RI Fundamentals of immune system physiology. M .: Medicine-Health, 2003. 227 p.
  2.  
  3. Sepiashvili RI Physiology of Toll-like receptors and their role in the regulation of the immune response. Theses. doc. XX Congress of physiol. Russian Federation, June 4-8, 2007, Moscow.
  4.  
  5. Sepiashvili RI, Balmasova IP Physiology of natural killers. M .: Medicine-Health, 2005. 456 p.
  6.  
  7. Tukhvatulin AI, Logunov D.Yu., Shcherbin DN Toll-like receptors and their adapter molecules. Biochemistry. 2010. 75 (9). pp. 1224-1243. Asprodites N., Zheng L., Geng D., Velasco-Gonzalez C., Sanchez-Perez L., Davila E. Engagement of Tolllike receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity . FASEB J. 2008. 22 (10) .p. 3628-3637. CrossRef PubMed PubMedCentral
  8.  
  9. Barreiro L.B., Ben-Ali M., Quach H., Laval G., Patin E., Pickrell J.K., Bouchier C., Tichit M., Neyrolles O., Gicquel B., Kidd J.R., Kidd K.K., Alcaïs A., Ragimbeau J., Pellegrini S., Abel L., Casanova J.L., Quintana- Murci L. Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense . PloS Genet. – 2009. – 5(7). – å1000562. CrossRef PubMed PubMedCentral
  10.  
  11. Barton G.M., Kagan J.C. A cee biological view of Toll-like receptor function: regulation through compartmentalization . Nat.Rev.Immunol. – 2009. – 9(8). – Ð. 535-542. CrossRef PubMed PubMedCentral
  12.  
  13. Basith S., Manavalan B., Lee G., Kim S.G., Choi S. Tolllike receptor modulators: a patent review (2006-2010) . Exp. Opin Ther PaT. – 2011. – 21(6). – Ð. 927–944. CrossRef PubMed
  14.  
  15. Engel A., Holt G., Lu H. The pharmacokinetics of Tolllike receptor agonists and the impact on the immune system . Expert Rev Clin. Pharmacol. – 2011. – 4(2). – Ð. 275–289. CrossRef PubMed PubMedCentral
  16.  
  17. Hanisch U., Johnson T., Kipnis J. Toll-like receptors: roles in neuroprotection . Trends Neurosci. – 2008. – 31(4). – Ð: 176-182. CrossRef PubMed
  18.  
  19. Hyang L.T., Paredes C.J., Papoutsakis E.T., Miller W.M. Gene expression analysis illuminates the transcriptional programs underlying the functional activity of ex vivo-expanded granulocytes . Physiol. Genomics. – 2007. – 31(1). – Ð.114-125. CrossRef PubMed
  20.  
  21. Jain S., Chodisetti S, Agrewala J.CD40 signaling synergizes with TLR-2 in the BCR independent activation of resting B cells . PLoS One. – 2011. –6(6). – e20651. CrossRef PubMed PubMedCentral
  22.  
  23. Jeneway C., Medzhitov R. Viral interfernce with Il-1 and toll signaling . Proñ. Natl. Acad. Sci. USA. – 2000. – 97(20). – Ð.10682–10683. CrossRef PubMed PubMedCentral
  24.  
  25. Kuhlicke J., Frick J., Morote-Garsia J., Rosenberger P., Eltzschig H.K. Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia . PloS One. –2007. – 2(12). – e1364. CrossRef PubMed PubMedCentral
  26.  
  27. Liang F., Huang N., Wang B., Chen H.Assessment of the role of TLR-4 in shear-stress-induced IL-8 gene transcription activation in vascular endothelial cells by gene mutation and gene transfection technology . Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. – 2002. – 19(4). – Ð. 667–672.
  28.  
  29. Lin Q., Li M., Fang D., Fang J., Su S.B. The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases . Int. Immunopharmacol. – May 18, 2011 [Epub ahead of print]. CrossRef PubMed
  30.  
  31. Lin Y., Chen H., Sun Y., Chen F. Antiviral role of tolllike receptors and cytokines against the new 2009 H1N1 virus infection . Mol. Biol. Rep. – May 21, 2011 [Epub ahead of print].
  32.  
  33. Macedo L., Pinhal-Enfield G., Alshits V., Elson G., Cronstein B.N., Leibovich S.J. Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors . Amer. J. Pathol. – 2007. – 171(6) . – P. 1774–1788. CrossRef PubMed PubMedCentral
  34.  
  35. Mishra B.B., Gundara U.M., Teale J.M. Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis . J. Neuroinflammation. – 2008. – 5. – P. 53. CrossRef PubMed PubMedCentral
  36.  
  37. Pasare C. Toll-like receptors: balancing host resistance with immune tolerance . Curr Opin Immunol. –2003. – 15(6) . – P. 677–682. CrossRef PubMed
  38.  
  39. Pasare C., Medzhinov R. Toll-like receptors: linking innate and adaptive immunity . Microbes Infect. – 6(15): 1382–1387, 2004. CrossRef PubMed
  40.  
  41. Roach J., Glusman G., Rowen L., Kaur A., Purcell M.K., Smith K.D., Hood L.E., Aderem A. The evolution of vertebrate Toll-like receptors . Proc Natl Acad Sci USA. – 2005. – 102(27) . – P. 9577–9582. CrossRef PubMed PubMedCentral
  42.  
  43. Salem M.L., Diaz-Montero C.M., El-Naggar S.A., Chen Y., Moussa O., Cole D.J. The TLR3 agonists poly (I:C) target CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice . Vaccine. – 2009. – 27(4) . – P. 549–557. CrossRef PubMed PubMedCentral
  44.  
  45. Smrz D., Iwaki S., McVicar D.W., Metcalfe D.D., Gilfillan A.M. TLR-mediated signaling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release . Eur. J. Immunol. – 2010. – 40(12) . – P. 3557–3569. CrossRef PubMed PubMedCentral
  46.  
  47. Takeda K. Toll-like receptor . Nihon Rinsho Meneki Gakkai Kaishi. – 2005. – 28(5). – P. 309–317. CrossRef PubMed
  48.  
  49. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defenñå . Nat Rev Immunol. – 2007. – 7(3). – P.179–190. CrossRef PubMed
  50.  
  51. Wan Y., Xiao H., Affolter J., Kim T.W., Bulek K., Chaudhuri S., Carlson D., Hamilton T., Mazumder B., Stark G.R., Thomas J., Li X. Interleukin-1 receptorassociated kinase 2 is critical for lipopolysaccharidemediated post-transcriptional control . J. Biol. Chem. – 2009. – 284(16) . – P. 10367–10375. CrossRef PubMed PubMedCentral
  52.  
  53. Wang Y, Lechner T. Induction of innate immunity in control of mucosal transmission of HIV . Curr. Opin. HIV AIDS. – Jul 2, 2011 [Epub ahead of print]. CrossRef PubMed
  54.  
  55. Wei T., Gong J., Rössle S.C., Jamitzky F., Heckl W.M., Stark R.W. A leucine-rich repeat assembly approach for homology modeling of the human TLR5-10 and mouse TLR11-13 ectodomains . J. Mol. Model. – 2011. – 17(1) . – P. 27–36. CrossRef PubMed
  56.  
  57. Wesch D., Peters C., Oberg H.H., Pietschmann K., Kabelitz D. Modulation of ãä T cell responses by TLR ligands . Cell Mol Life Sci. – 2011. – 68(14). – P. 2357–2370. CrossRef PubMed
  58.  
  59. Yoshimura A, Ohishi HM, Aki D, Hanada T. Regulation of TLR signaling and inflammation by SOCS family proteins . J. Leukoc. Biol. – 2004. – 5(3) . –P. 422–427. CrossRef PubMed

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2020.